Pharmacokinetics of Escalating Doses of Intravenous Repinotan in Healthy Male Volunteers

By Roland Heinig   Michael F. Böttcher  

Clinical Drug Investigation, Vol. 25, Iss. 2, 2005-01 ,pp. : 115-123

Adis International

Access to resources Recommend Favorite

Effect of age on the pharmacokinetics of fimasartan (BR-A-657)

By Lee Hae Won   Lim Mi-sun   Seong Sook Jin   Lee Joomi   Park Jeonghyeon   Seo Jeong Ju   Cho Joo-Youn   Yu Kyung-Sang   Yoon Young-Ran  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1337-1344

Informa Healthcare

Access to resources Recommend Favorite

Effect of Gender and Race on the Pharmacokinetics of Pentamidine in HIV-Infected Patients

By Conte J.E.J.   Duncan S.   McKenna E.   Zurlinden E.  

Clinical Drug Investigation, Vol. 17, Iss. 4, 1999-04 ,pp. : 293-299

Adis International

Access to resources Recommend Favorite

Effect of Gender on the Tolerability, Safety and Pharmacokinetics of Clazosentan Following Long-Term Infusion

By van Giersbergen Paul L.M.   Dingemanse Jasper  

Clinical Drug Investigation, Vol. 27, Iss. 11, 2007-01 ,pp. : 797-802

Adis International

Access to resources Recommend Favorite

An open‐label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 112-120

John Wiley & Sons Inc

Access to resources Recommend Favorite